Bisphosphonates prevent bone loss associated with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/675 (2006.01) A61K 31/66 (2006.01)

Patent

CA 2223400

Bisphosphonate, particularly alendronate, can prevent or treat bone loss associated with immunosuppressive therapy, whether or not the immunosuppressive therapy is associated with an organ transplant.

Les bisphosphonates, en particulier l'alendronate, peuvent prévenir ou traiter la déperdition osseuse liée à une thérapie d'immunodépression, que cette thérapie soit ou non associée à une transplantation d'organe.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bisphosphonates prevent bone loss associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bisphosphonates prevent bone loss associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisphosphonates prevent bone loss associated with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2088282

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.